Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07200869

Outcomes of Vaso-occlusive Crisis in Pediatric Sickle Cell Disease

This study aims to assess the incidence and clinical outcomes of vaso-occlusive crises in pediatric patients with sickle cell disease. Data will be collected and analyzed to identify risk factors and related complications.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Sickle cell disease is a hereditary blood disorder characterized by the presence of sickle-shaped red blood cells, which leads to recurrent vaso-occlusive crises (VOC). These painful episodes are among the most common causes of hospitalization and are associated with significant morbidity in pediatric patients. Despite ongoing improvements in the management of sickle cell disease, there is still limited data describing the incidence, risk factors, and clinical outcomes of VOC in children within our population.

This study is designed to retrospectively analyze medical records of pediatric patients with sickle cell disease at Faculty of Medicine, Assiut University. The primary aim is to estimate the incidence of vaso-occlusive crises and to identify the most frequent complications. Secondary objectives include evaluating treatment approaches, length of hospital stay, and clinical outcomes. Findings from this study are expected to provide valuable insights that may help improve clinical care strategies and preventive measures for affected children.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children aged 1-18 years. Confirmed diagnosis of sickle cell anemia by hemoglobin electrophoresis or high-performance liquid chromatography .

History of at least one hospital visit or admission for vaso-occlusive crisis

Exclusion criteria

  • Patients with other hemoglobinopathies (e.g., thalassemia). Patients with incomplete medical records. Children with coexisting chronic diseases that may confound pain crises .

Treatment and study plan

No intervention

Other

retrospective observational study. No intervention will be administered; data will be collected from existing medical records of pediatric sickle cell patients at Assiut University Hospital.

Primary outcomes

  1. Incidence of vaso-occlusive crisis in pediatric sickle cell patients

    Time frame: Retrospective review of medical records from 2019 to 2024

    Frequency of vaso-occlusive crisis episodes will be identified through retrospective chart review of pediatric sickle cell patients.

Secondary outcomes

  1. Complications associated with vaso-occlusive crisis (e.g., acute chest syndrome, stroke, infections)

    Time frame: Throughout the study period (2019-2024)

    Complications related to vaso-occlusive crisis will be identified and documented from patient records.

Study contacts

Contact information is provided by the study sponsor or research team.

Assiut University research office

CONTACT

[email protected]

Nadia Fawzy, Pediatrician

CONTACT

[email protected]

+201552865958 ext. +201552865958

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Vaso-occlusive Crisis Incidence and Outcomes in a Pediatric Sickle Cell Population

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Oct 1, 2025
Registry last updated
Oct 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.